CMMRD tumor identification requires the use of the tests applied for LS identification, namely immunohistochemical (IHC) assessment of the four MMR proteins expression and/or analysis of microsatellite instability (MSI) [15]. This evidence concerns the gene MRC1 and neoplasm.